11-3-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com

Stephen Bernard, AP Business Writer

Stocks waver ahead of Federal Reserve announcement

Stocks trade in tight range amid questions over about size of Fed stimulus program

NEW YORK (AP) — Stocks traded in a tight range Wednesday as investors turned their attention to the Federal Reserve after there were few surprises in the midterm elections.

The Dow Jones industrial average fell 19 points in late morning trading, but still near its highest closing level in more than two years. Broader indexes also fell slightly.

By the end of the day, investors will likely know exactly how much the Fed plans to spend to stimulate the economy. The central bank has hinted for two months it plans to buy Treasurys to drive interest rates lower in an attempt to spark lending and spending. However, there was still plenty of debate about the size and length of the program, particularly in the past few days.

Lawrence Creatura, a portfolio manager at Federated Investors, said the market has factored in expectations that the Fed will buy $500 billion or less of Treasury bonds. A bigger program would most likely drive stocks higher, though there is a small possibility it could spook investors' views about the health of the economy, Creatura said.

Yesterday's Top Performing Small Cap Stock:

Concordis Group, Inc. (Pink Sheets: CNGI)

Concordis Group, Inc. was a SmallCapVoice.com top performer closing up over 12% on trading volume of 25,900 shares.

Concordis Group, Inc. is a diversified holding company that provides investment brokerage services and business insurance products for its clients. Concordis Group, Inc. provides investment products and risk management solutions through its two wholly owned subsidiaries, Concordis Insurance SPC and Puritan Securities, Inc.

Concordis Group's go-to-market strategy is based upon strong organic growth combined with strategic acquisitions of companies in the financial services and insurance industries that create additional synergy, have positive cash-flow, exhibit strong long-term growth potential, and have highly qualified management teams.

Today's SmallCapVoice.com Hot Stock to Watch:

Infrax Systems, Inc. IFXY

Infrax Systems offers a series of interrelated operational management, communications, and grid security related products and services known as Secure Intelligent Energy Platform (SIEP). Infrax's products enable a comprehensive and unified solution for communications and applications management of the Smart Grid. SIEP™ incorporates a wide array of communications, security, device and data management tools for Smart Grid applications such as advanced metering solutions and grid optimization. SIEP platform creates a unified solution to securely manage Advanced Metering Infrastructure (AMI) and distribution automation. Infrax's secure smart grid platform incorporates a communications transport and management system, (Grid Mesh™), device and data security management, and ultimately secures intelligent endpoint devices (SIED). The secure management of the “last mile” backhaul will be necessary for utilities to implement Smart Grid applications including AMI, real-time pricing, Demand Side Management (DSM), Distribution Monitoring and Automation. When combined, these applications can offer economic, operational and environmental benefits for utilities, and ultimately the utility's customers.

Other Small Cap News

Cleveland BioLabs, Inc. CBLI

Cleveland BioLabs and Incuron Receive $489,000 in Qualifying Therapeutic Discovery Project Grants

BUFFALO, NY–(Marketwire – 11/02/10) – Cleveland BioLabs, Inc. CBLI today announced that the Company and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, have each been awarded grants of $244,479 under the highly competitive Qualifying Therapeutic Discovery Project Program, created by the Affordable Care Act of 2010. The Cleveland BioLabs award was received on November 1, 2010, and the Incuron award will be distributed on January 30, 2011.

Pressure BioSciences, Inc. PBIO

Pressure BioSciences, Inc. Awarded $244,000 Therapeutic Discovery Grant

SOUTH EASTON, Mass., Nov. 2, 2010 (GLOBE NEWSWIRE) — Pressure BioSciences, Inc. PBIO (“PBI” and the “Company”) today announced that it has been awarded a Therapeutic Discovery Grant (“TDG”) for $244,479.25. The TDG Program is part of the Patient Protection and Affordable Care Act of 2010 signed into law on March 23, 2010. Grant funds are not taxable for federal income tax purposes, do not require performance of any additional studies or services, and are immediately available to the Company.

Zalicus Inc. ZLCS

Zalicus Awarded $244,000 Therapeutic Discovery Project Grant

- Grant Supports Development of Synavive for Immuno-Inflammatory Conditions -

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Zalicus Inc. ZLCS, innovators in the treatment of pain and immuno-inflammatory disease, today announced that it has been awarded a $244,000 grant under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grant, which targets therapeutic discovery projects that show potential to result in new therapies to treat areas of unmet medical need or treat chronic or acute diseases and conditions potentially resulting in reduced health care costs, was awarded to Zalicus to help fund the further clinical development of Synavive™, a clinical-stage product candidate in development for immuno-inflammatory diseases such as rheumatoid arthritis.

GenMark Diagnostics, Inc. GNMK

GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate

CARLSBAD, Calif.–(BUSINESS WIRE)– GenMark Diagnostics, Inc. GNMK, a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States. The agreement includes an option to extend the license on a global basis. The financial terms of the license transaction were not disclosed.

GenVec, Inc. GNVC

GenVec Awarded Grant for Qualifying Therapeutic Development Project

GAITHERSBURG, Md., Nov. 2 /PRNewswire/ — GenVec, Inc. GNVC announced today that it was awarded a cash grant of approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project (“QTDP”) program.

pSivida Corp. PSDV

pSivida Corp Awarded Two Therapeutic Discovery Project Grants Totaling $489,000

WATERTOWN, Mass.–(BUSINESS WIRE)– pSivida Corp. PSDV, a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.

Marina Biotech, Inc. MRNA

Marina Biotech Announces Clinical Protocol Approval of CEQ508 at Massachusetts General Hospital

Data Safety Monitoring Board Assembled With World Class Key Opinion Leaders

BOTHELL, WA–(Marketwire – 11/03/10) – Marina Biotech, Inc. MRNA, a leading RNAi-based drug discovery and development company, today announced institutional site approval at Massachusetts General Hospital (MGH), for their clinical trial protocol for Familial Adenomatous Polyposis (FAP), allowing trial initiation including patient enrollment and dosing. The protocol was independently reviewed and approved by the Institutional Review Board (IRB) and the Institutional Biosafety Committee (IBC) at MGH, a world class medical center and clinical trial site.

Scientific Games Corporation SGMS

Scientific Games Awarded Iowa Lottery Systems Contract and Instant Ticket Contract Extension

NEW YORK, Nov. 3, 2010 /PRNewswire/ — Scientific Games Corporation SGMS today announced it has been awarded the integrated Lottery Gaming Systems contract by the Iowa Lottery. The new contract includes the installation of new sales terminals, a new terminal communications network and a full suite of data processing servers. The Iowa Lottery's 2,500 retail locations will be equipped with the next-generation WAVE™ terminal as well as the industry's most innovative ticket checkers, peripherals, and displays. The contract, which was awarded through a competitive procurement process, begins July 2011, has an initial term of seven years and includes three additional one-year contract extension options.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

The SmallCapVoice.com, Inc. Daily Highlights is an electronic publication, and is for informational purposes only. The Small Cap Voice Daily Highlights covers both client and non client issuers. Non client issuer's news is listed under other small cap news. SmallCapVoice is an electronic publication providing information on selected public companies. All companies profiled on this website pay cash or restricted stock to SmallCapVoice as consideration for the electronic dissemination of the company's information and our comments about the company. Section 17(b) of the Securities Act of 1933 requires that SmallCapVoice fully disclose the type consideration (i.e. cash, restricted stock, and restricted stock with registration rights, stock options, stock warrants, or other type consideration) and the specific amount of the consideration our company receives or will receive, directly or indirectly, from an issuer, underwriter, or dealer. No information contained in our website, e-mail communications or our publications should be considered as a solicitation to purchase or sell the securities of the profiled companies. SmallCapVoice is not a registered investment advisor or a registered securities broker dealer. We do not undertake or represent to make investment recommendations or to give advice pertaining to the purchase or sale of the securities mentioned in our web site, e-mail communications or publications. The information contained in our website, e-mail communications and publications are carefully compiled by SmallCapVoice from public sources that we believe to be reliable. SmallCapVoice, however, does not guarantee the accuracy of any information contained in our website, e-mail communications or publications. This material is not a substitute for either one's own thorough investigation of an investment opportunity or the exercise of good business judgment. SmallCapVoice does not endorse, independently verify, or assert the truthfulness or reliability of any statements or data obtained from third party sources that are published by us about the profiled companies in our website articles, e-mail communications or publications, but we do not publish information that we know is incorrect. Investors should not rely solely on the information contained in our website, e-mail communications or publications when making investment decisions. Instead, investors should use the information provided on the profiled companies as a starting point for conducting additional research that will permit them to form their own opinions regarding the appropriateness of an investment in the profiled company's securities. SmallCapVoice does not warrant, represent or guaranty that there has been no change in the affairs of the profiled company since the date that information was published on this website, in e-mail communications or in our publications regarding a profiled company or after the date of the profiled company's press releases or other information disseminated via our website or publications. If you become aware of any change of circumstances related to any website article, e-mail communication or publication, please notify us immediately. See the Contact Us page for the appropriate e-mail address. The information contained in our website, e-mail communications and publications pertains to microcap, small cap and/or other thinly traded securities which by their very nature involve an extremely high degree of risk. An investment in these type of securities could result in the loss of some or all of an investment in the company. In addition, due to the illiquid nature of some of these securities, an investor may find encounter difficulties in liquidating the securities. SmallCapVoice may liquidate the stock consideration it receives at any time it deems it appropriate to do so after the required six-month holding period has run after the completion of the services for which SmallCapVoice was paid in stock. The liquidation of our stock may have a negative impact on the securities of the company liquidated, including decreased market value and/or dilution of the company's securities. The following companies have paid, and/or have agreed to pay SmallCapVoice to: distribute the company's information and reports on this website, to send e-mail communications; to send publications by mail, to post company Internet links on our website, and to compile and/or to distribute reports in an e-mail newsletter.

We encourage our readers to use caution when investing and educate themselves at the web sites of the Securities and Exchange Commission (“SEC”) at www.sec.gov and/or the National Association of Securities Dealers (“NASD”) at www.nasd.com. We encourage you to study the SEC's policies regarding online newsletters at http://www.sec.gov/answers/newsltr.htm. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our site.

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com